» Articles » PMID: 2952364

Changes in Myosin Isoenzymes, ATPase Activity, and Contraction Duration in Rat Cardiac Muscle with Aging Can Be Modulated by Thyroxine

Overview
Journal Circ Res
Date 1987 Feb 1
PMID 2952364
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

To determine whether the relative decline in cardiac myosin isoenzyme V1 with maturation continues progressively into senescence and whether thyroxine could reverse age-associated changes in the myosin isoenzyme profile and contraction, rats 2, 8, and 24 months old were treated with thyroxine, 6.4 mg/kg, for 7 days. Myosin isoenzymes, Ca2+-myosin ATPase activities, and isometric contractile function were measured in cardiac preparations from thyroxine-treated animals and age-matched controls. Right ventricular hypertrophy did not occur with aging in controls. Thyroxine increased right ventricular weight in each age group compared to the control group. Body weight decreased by 10% in all thyroxine-treated rats. The relative right ventricular V1 isoenzyme content progressively decreased from 75 +/- 1% to 54 +/- 1% and 14 +/- 1% in controls at 2, 8, and 24 months, respectively, and was associated with a reciprocal increase in V3 myosin isoenzyme. Ca2+-myosin ATPase activity also progressively declined monotonically with age in the control rats from 854 +/- 28 nmol Pi/mg prot/min at 2 months to 529 +/- 28 nmol Pi/mg prot/min at 24 months. Thyroxine administration increased right ventricular V1 at each age to 97 +/- 2%, 73 +/- 2%, and 59 +/- 2% at 2, 8, and 24 months, respectively. A thyroxine induced increase in the Ca2+-myosin ATPase activity could be detected only in the 24-month-old animals.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Mechanisms and implications of sex differences in cardiac aging.

Yusifov A, Woulfe K, Bruns D J Cardiovasc Aging. 2022; 2.

PMID: 35419571 PMC: 9004711. DOI: 10.20517/jca.2022.01.


The Effects of Healthy Aging on Right Ventricular Structure and Biomechanical Properties: A Pilot Study.

Kia D, Shen Y, Bachman T, Goncharova E, Kim K, Simon M Front Med (Lausanne). 2022; 8:751338.

PMID: 35083230 PMC: 8784691. DOI: 10.3389/fmed.2021.751338.


Age-Related Resistance to Thyroid Hormone Action.

Mooradian A Drugs Aging. 2019; 36(11):1007-1014.

PMID: 31512083 DOI: 10.1007/s40266-019-00711-7.


Molecular Tension Probes to Investigate the Mechanopharmacology of Single Cells: A Step toward Personalized Mechanomedicine.

Galior K, Ma V, Liu Y, Su H, Baker N, Panettieri Jr R Adv Healthc Mater. 2018; 7(14):e1800069.

PMID: 29785773 PMC: 6105437. DOI: 10.1002/adhm.201800069.


Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.

Wang Y, Carmona C, Hickman J, Shuler M Adv Healthc Mater. 2017; 7(2).

PMID: 29205920 PMC: 5805562. DOI: 10.1002/adhm.201701000.